Keyphrases
12-lead Electrocardiogram
8%
Abnormal Splicing
25%
Adverse Events
8%
Alu Retrotransposon
25%
Antisense nucleic Acids
25%
Cardiomyopathy
25%
Cell Membrane
25%
Clinical Course
25%
Clinical Features
50%
Clinical Research
8%
Clinical Treatment
50%
Clinical Trials
25%
Compound Heterozygous mutation
8%
Cytidine
25%
Definite Diagnosis
8%
Diphosphate
25%
Dystroglycan
25%
Echocardiography
8%
Exon Trapping
50%
Founder Variant
25%
Fukuyama Congenital muscular Dystrophy
100%
Gene Products
25%
Genetic Testing
8%
Glycosyltransferase
25%
Gross Motor Function Classification System (GMFCS)
8%
Immunological Tests
8%
Insertion mutation
8%
Insurance
25%
Investigator-initiated Trials
8%
Japan
25%
Membrane Components
25%
Motor Function
8%
Muscular Dystrophy
25%
Neuronal Migration Defect
25%
Number of Patients
25%
O-mannosyl Glycan
25%
Ocular Complications
25%
Oral Prednisolone
16%
Patient's Will
8%
Phase II Clinical Trial
75%
Phase II Trial
8%
Prednisolone
41%
Prodrug Therapy
25%
Respiratory Failure
25%
Retrotransposon
25%
Ribitol
25%
Ribitol-5-phosphate
25%
Royalty Payments
50%
Safety Profile
8%
Severe Disease
25%
SINE-VNTR-Alu
25%
Splicing Modulation
25%
SpO2
8%
Steroid Therapy
50%
Structural Anomalies
25%
Therapeutic Advances
50%
Therapeutic Agents
8%
Vital Signs
8%
Biochemistry, Genetics and Molecular Biology
Antisense
25%
Cell Membrane
25%
Clinical Research
7%
Clinical Study
25%
Clinical Trial
100%
Cytidine Diphosphate
25%
Dystroglycan
25%
Electrocardiography
7%
Exon Trapping
50%
Gene Product
25%
Genetic Screening
7%
Glycosyltransferase
25%
Hope
25%
Laboratory Test
7%
Membrane Component
25%
Motor Performance
14%
Nucleic Acid
25%
Polysaccharide
25%
Precursor
25%
Prednisolone
50%
Retrotransposon
50%
Ribitol
50%
Variable Number Tandem Repeat
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
7%
Agents Acting on the Eye
7%
Clinical Feature
50%
Clinical Research
7%
Clinical Study
8%
Clinical Trial
66%
Cytidine Diphosphate
8%
Disease Course
8%
Diseases
8%
Dystroglycan
8%
Fukuyama Congenital Muscular Dystrophy
100%
Glycan
8%
Glycosyltransferase
8%
Muscular Dystrophy
8%
Myocardial Disease
8%
Neuronal Migration Disorder
8%
Nucleic Acid
8%
Prednisolone
50%
Prodrug
8%
Respiratory Failure
8%
Ribitol
16%